Andrew J Massey

Summary

Affiliation: Granta Park
Country: UK

Publications

  1. doi request reprint A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
    Andrew J Massey
    Vernalis R and D Ltd, Granta Park, Cambridge, CB21 6GB, UK
    Cancer Chemother Pharmacol 66:535-45. 2010
  2. pmc Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor
    Andrew J Massey
    Vernalis R and D Ltd, Granta Park, Cambridge, United Kingdom
    PLoS ONE 5:e13123. 2010
  3. pmc NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
    Michael Rugaard Jensen
    Novartis Institutes for BioMedical Research, Oncology Research, Klybeckstrasse 141, CH 4057 Basel, Switzerland
    Breast Cancer Res 10:R33. 2008
  4. doi request reprint Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity
    Alba T Macias
    Vernalis R and D Ltd, Granta Park, Great Abington, Cambridge, CB21 6GB, UK
    J Med Chem 54:4034-41. 2011
  5. doi request reprint Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design
    Douglas S Williamson
    Vernalis R and D Ltd, Granta Park, Great Abington, Cambridge CB21 6GB, United Kingdom
    J Med Chem 52:1510-3. 2009
  6. doi request reprint Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling
    Hana Tabusa
    Department of Oncology, Vernalis R and D Ltd, Granta Park, Cambridge, CB21 6GB, United Kingdom
    Mol Cancer Res 11:109-21. 2013

Collaborators

  • Douglas S Williamson
  • Martin J Drysdale
  • James B Murray
  • Nicolas Foloppe
  • Hana Tabusa
  • Alba T Macias
  • Michael Rugaard Jensen
  • Teresa Brooks
  • Mike Wood
  • Alexandra Clay
  • Pawel Dokurno
  • Yikang Wang
  • Natalia Matassova
  • Terry Shaw
  • Lindsey Terry
  • Rob Howes
  • Allan E Surgenor
  • Christopher J Graham
  • Rachel Parsons
  • Jenifer Borgognoni
  • Zoe Daniels
  • Geraint L Francis
  • Nicola Allen
  • Alan Buckler
  • Josef Brueggen
  • Patrick Chene
  • Joseph Schoepfer
  • Thomas Radimerski
  • Chantale T Guy
  • Cornelia Quadt
  • Robert Cozens
  • Carlos Garcia-Echeverria

Detail Information

Publications6

  1. doi request reprint A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
    Andrew J Massey
    Vernalis R and D Ltd, Granta Park, Cambridge, CB21 6GB, UK
    Cancer Chemother Pharmacol 66:535-45. 2010
    ....
  2. pmc Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor
    Andrew J Massey
    Vernalis R and D Ltd, Granta Park, Cambridge, United Kingdom
    PLoS ONE 5:e13123. 2010
    ..We have identified a novel inhibitor of these kinases and utilized this molecule to probe the functional interplay between these two checkpoints...
  3. pmc NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
    Michael Rugaard Jensen
    Novartis Institutes for BioMedical Research, Oncology Research, Klybeckstrasse 141, CH 4057 Basel, Switzerland
    Breast Cancer Res 10:R33. 2008
    ..HSP90 has emerged in recent years as a promising new target for anticancer therapies...
  4. doi request reprint Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity
    Alba T Macias
    Vernalis R and D Ltd, Granta Park, Great Abington, Cambridge, CB21 6GB, UK
    J Med Chem 54:4034-41. 2011
    ..X-ray crystal structures of Grp78 bound to ATP, ADPnP, and adenosine derivative 10 revealed differences in the binding site between Grp78 and homologous proteins...
  5. doi request reprint Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design
    Douglas S Williamson
    Vernalis R and D Ltd, Granta Park, Great Abington, Cambridge CB21 6GB, United Kingdom
    J Med Chem 52:1510-3. 2009
    ..Exposure of compound 12 to HCT116 cells caused significant reduction in cellular levels of Raf-1 and Her2 at concentrations similar to that which caused cell growth arrest...
  6. doi request reprint Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling
    Hana Tabusa
    Department of Oncology, Vernalis R and D Ltd, Granta Park, Cambridge, CB21 6GB, United Kingdom
    Mol Cancer Res 11:109-21. 2013
    ..These results support a role for the PAKs in the proliferation of mutant KRAS-driven colorectal carcinoma cells via pathways not involving RAF/MEK/ERK and PI3K/AKT signaling...